SEC Form D · Amendment · filed March 9, 2023
Circular Genomics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Nikolaos Mellios · Albuquerque, NMExec · Director · PromoterWaneta T. Tuttle · Albuquerque, NMDirectorPaul Sargeant · Albuquerque, NMExec · DirectorJoseph Cook Iii · Nashville, TNDirectorFortunado Rocca · Albuquerque, NMDirectorAlexander Hafez · Albuquerque, NMExec · Director · PromoterCathy Petti · Brandenton, FLDirectorBlivin David · Santa Fe, NMDirectorDavid A. Smolen · SCOTTSDALE, AZExec · Director · PromoterSamuel L. Degenhard · Gunnison, CODirectorTsang Ming Jiang · Fremont, CADirectorGabi Lewis · New York, NYExec · Director · PromoterClark A. Harman · New York, NYDirectorChristopher T. Greene, Jr · New York, NYDirectorLee C. Fleisher, M.D · Aspen, COExec · DirectorStephen Mckernan · Albuquerque, NMExecEdward Martinson · New York, NYExec · Director · PromoterMichael Kronenberg · Tomball, TXExec · Director · PromoterDavid C. Ott · Greenwich, CTDirectorNigel Woods · Dublin, IrelandDirectorManeesh Juhnjuhnwala · Overland Park, KSDirectorEric Zaunscherb · Scottsdale, AZExec · DirectorJessica Van Den Akker · Scottsdale, AZDirectorStephen Mckernan · Albuquerque, NMExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗